The historical priorities were rest, relief of painful arthritis, and repeated examination for carditis; modern treatment also eradicates preceding streptococcal infection and prevents recurrences. In an 1865 account, the patient would be nursed in bed, the painful anatomical joints supported, drinks and tolerable nourishment supplied, and temperature, pulse, breathing and urine observed. Moist flannel applications and opium preparations were used for severe pain and sleeplessness. Alkaline salts were commonly prescribed under a theory that the disease involved an abnormal acid material; attempts to make the urine alkaline were a therapeutic practice, not proof that an acid caused the disease. There was already disagreement about the value of specific drugs and blistering agents. A contemporary critique describes these competing treatments and stresses the inadequacy of small uncontrolled case series.[ref]
Remarks on the treatment of acute rheumatism in the British Medical Journal (1865). 14 January, p. 31, ordinary management and criticism of blistering
The important complications are rheumatic carditis, including valvulitis and sometimes pericarditis, with possible heart failure; Sydenham's chorea is another manifestation. New dyspnoea, a changed heart murmur, chest pain, a pericardial friction rub, or signs of circulatory failure require reassessment rather than stronger treatment of the painful anatomical joint alone. Historically, local bleeding, Mercury and counterirritation were employed against supposed cardiac inflammation. Their historical use does not justify them now. A heart examination also matters when arthritis improves, because improvement of pain does not establish freedom from cardiac injury.[ref]
Clinical Guidance for Acute Rheumatic Fever by CDC. clinical manifestations: carditis, arthritis and chorea
Present management confirms the diagnosis and cardiac involvement with appropriate clinical criteria, electrocardiography and echocardiography. Penicillin or an appropriate alternative eradicates residual group A streptococci, even if the throat symptoms have resolved. An anti-inflammatory drug relieves arthritis; severe carditis, heart failure or disabling Sydenham's chorea needs specialist management. Fluid-retaining heart failure can require a diuretic with monitoring of renal function and electrolytes; treatment is selected according to haemodynamic findings. The 2025 guideline allows corticosteroids for selected severe carditis or pericarditis with effusion, under specialist care. Mild Sydenham's chorea may need only rest and a calm environment; greater functional impairment can justify carbamazepine or another carefully selected symptomatic medicine. These measures accompany, rather than replace, antibiotic prophylaxis. Secondary antibiotic prophylaxis reduces future attacks and further valve injury. Neither aspirin nor a later salicylate regimen should be presented as ordinary Oxford practice in 1865. These are historical explanations and general medical principles, not a treatment plan for an individual.[ref]
Australian guideline for acute rheumatic fever and rheumatic heart disease (2025). acute management, cardiac assessment, management of chorea and secondary prophylaxis
The treatment depends on the cause of acute pericarditis, the person's strength and the presence of pericardial effusion, myocarditis or circulatory failure. In an 1866 answer, rest, relief of pain and repeated assessment of the heart are more defensible starting points than an indiscriminate attempt to suppress every sign of inflammation by depletion.
The bedside assessment would include the history of rheumatic illness, chest pain, a pericardial friction rub, the character of the pulse, breathing, the extent of cardiac dullness on percussion and changes in the heart sounds. Serial examination matters: disappearance of a pericardial friction rub need not mean recovery if fluid is separating the inflamed surfaces. Increasing oppression of breathing, weakness or a failing pulse would require reconsidering both the disease and the treatment. Auscultation with a stethoscope and careful repeated percussion supplied information that modern imaging now refines.
Period practice included local bloodletting with medicinal leeches, counterirritation with a blistering agent, opium for pain and rest, and disputed Mercury treatment intended to alter inflammatory exudation. A robust adult early in an apparently vigorous inflammatory attack was treated differently by depletion advocates from an exhausted person with anaemia, previous blood loss or advanced kidney disease. Even in that framework, a rapid weak pulse was not a command to remove more blood. Nor was Mercury an uncontested standard: a medical address published in December 1866 specifically listed its use in pericarditis among unresolved therapeutic questions.[ref]
Introductory Address at the Public Opening of the Medical Session, 1866–67 by William Tennant Gairdner. p. 294, therapeutic uncertainties concerning mercury in pericarditis and diuretics in Bright's disease
Modern correction: establish the diagnosis, identify complications and use cause-directed treatment rather than bloodletting or mercurialization. Electrocardiography, inflammatory markers, troponin where myocardial injury is suspected and echocardiography help distinguish uncomplicated pericarditis from important associated disease. A typical uncomplicated inflammatory episode is treated with aspirin or a suitable nonsteroidal anti-inflammatory drug, usually with colchicine and appropriate gastroprotection. Renal impairment, gastrointestinal bleeding, interactions and a specific infectious or systemic cause can modify this plan. Corticosteroids have selected indications and are not the routine first choice. Activity is restricted during active disease and return to exertion follows reassessment.[ref]
2025 ESC Guidelines for the management of myocarditis and pericarditis. Diagnostic assessment; section 6.2.2, pharmacological therapy for pericarditis
A large pericardial effusion requires attention to its haemodynamic effect, not merely its size. Cardiac tamponade requires urgent specialist drainage and stabilization. Purulent disease requires treatment of the infection and drainage; associated myocarditis or a systemic cause changes management further.[ref]
2025 ESC Guidelines for the management of myocarditis and pericarditis. Pericardial effusion and cardiac tamponade management pathways
These distinctions explain why treatment cannot be fixed solely by the label “acute”.